o-(glucuronic acid 2-sulfate)-(1--4)-o-(2,5)-anhydromannitol 6-sulfate has been researched along with verapamil in 1 studies
Studies (o-(glucuronic acid 2-sulfate)-(1--4)-o-(2,5)-anhydromannitol 6-sulfate) | Trials (o-(glucuronic acid 2-sulfate)-(1--4)-o-(2,5)-anhydromannitol 6-sulfate) | Recent Studies (post-2010) (o-(glucuronic acid 2-sulfate)-(1--4)-o-(2,5)-anhydromannitol 6-sulfate) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
27 | 1 | 15 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Busse, D; Drescher, S; Eichelbaum, M; Fromm, MF; Kühlkamp, V; Mörike, K | 1 |
1 trial(s) available for o-(glucuronic acid 2-sulfate)-(1--4)-o-(2,5)-anhydromannitol 6-sulfate and verapamil
Article | Year |
---|---|
Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
Topics: Administration, Oral; Aged; Area Under Curve; Atrial Fibrillation; Blood Pressure; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Chronic Disease; Disaccharides; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Exercise Test; Female; Glucuronates; Half-Life; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Stereoisomerism; Tissue Distribution; Verapamil | 2001 |